JY
IRD

Jeff Yass’s Opus Genetics IRD Stock Holding History

Jeff Yass’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$809K Sell
196,897
-626,486
-76% -$2.92M ﹤0.01% 8756
2026
Q1 		$3.75M Buy
823,383
+621,748
+308% +$2.15M ﹤0.01% 4803
2025
Q4 		$405K Buy
201,635
+181,422
+898% +$368K ﹤0.01% 9263
2025
Q3 		$33.4K Buy
20,213
+2,910
+17% +$3.62K ﹤0.01% 11959
2025
Q2 		$16.3K Sell
17,303
-5,796
-25% -$5.37K ﹤0.01% 12362
2025
Q1 		$22.7K Buy
+23,099
New +$25.8K ﹤0.01% 12079
2024
Q4 		– Sell
-49,755
Closed -$65.2K – 13466
2024
Q3 		$65.2K Buy
49,755
+3,178
+7% +$4.89K ﹤0.01% 11275
2024
Q2 		$71.3K Buy
46,577
+3,987
+9% +$6.89K ﹤0.01% 11235
2024
Q1 		$85.6K Buy
42,590
+20,385
+92% +$51.7K ﹤0.01% 11302
2023
Q4 		$66.8K Sell
22,205
-33,795
-60% -$99.9K ﹤0.01% 11578
2023
Q3 		$188K Buy
+56,000
New +$225K ﹤0.01% 10300
2023
Q2 		– Sell
-14,751
Closed -$70K – 13337
2023
Q1 		$55.3K Sell
14,751
-15,451
-51% -$55.5K ﹤0.01% 11659
2022
Q4 		$107K Sell
30,202
-6,391
-17% -$16.8K ﹤0.01% 10908
2022
Q3 		$74K Sell
36,593
-8,040
-18% -$17.3K ﹤0.01% 11953
2022
Q2 		$86K Sell
44,633
-7,490
-14% -$17K ﹤0.01% 11614
2022
Q1 		$169K Sell
52,123
-11,356
-18% -$38.9K ﹤0.01% 11443
2021
Q4 		$237K Buy
63,479
+22,685
+56% +$90.9K ﹤0.01% 11069
2021
Q3 		$210K Sell
40,794
-18,378
-31% -$84.7K ﹤0.01% 11388
2021
Q2 		$312K Buy
+59,172
New +$294K ﹤0.01% 10703
2018
Q1 		– Sell
-380
Closed -$37K – 10332
2017
Q4 		$37K Buy
+380
New +$38.6K ﹤0.01% 8987
2017
Q3 		– Sell
-21,163
Closed -$2.9M – 9759
2017
Q2 		$2.9M Buy
+21,163
New +$4.11M ﹤0.01% 3214
2016
Q1 		– Sell
-38
Closed -$7K – 9781
2015
Q4 		$7K Buy
+38
New +$8.08K ﹤0.01% 9308
2015
Q2 		– Sell
-31
Closed -$11K – 10530
2015
Q1 		$11K Sell
31
-76
-71% -$27.6K ﹤0.01% 9305
2014
Q4 		$36K Buy
+107
New +$36.9K ﹤0.01% 9426

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jeff Yass's IRD Position: Q2 2026 in Review

Jeff Yass reduced its Opus Genetics (IRD) stake by 76% in Q2 2026, selling an estimated $2.92M and leaving 196,897 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #8756.

Jeff Yass first reported a position in IRD in Q4 2014 and has held it in 24 quarters since. The position peaked at $3.75M in Q1 2026. 102 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Jeff Yass held 196,897 shares of Opus Genetics worth $809K as of Q2 2026.
  • Jeff Yass sold 626,486 Opus Genetics shares in Q2 2026, an estimated $2.92M.
  • Opus Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8756 holding.
  • Jeff Yass first reported a position in Opus Genetics in Q4 2014 and has held it in 24 quarters since.
  • Jeff Yass's Opus Genetics position peaked at $3.75M in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.